leukemia
Supportive Care and Other Tools for Managing Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
In patients who received prior CLL/SLL-directed therapy but require additional treatment, decisions may depend on ...
APRIL 29, 2025
Blinatumomab Increases Disease-Free Survival for Children With Leukemia
Children with B-acute lymphoblastic leukemia who received blinatumomab plus standard chemotherapy were 61% less ...
DECEMBER 11, 2024
FDA Approves Revuforj for Relapsed or Refractory Acute Leukemia With a KMT2A Translocation
The FDA approved Revuforj, a menin inhibitor, for relapsed or refractory acute leukemia with a lysine ...
NOVEMBER 18, 2024
Key Treatment Principles and Recent Updates In the Management of Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
CLL is a lymphoproliferative disorder characterized by the accumulation of circulating mature B cells that are ...
MARCH 20, 2024
In Highly Pretreated KMT2A-Rearranged Leukemia, Novel Targeted Therapy Achieves MRD Negativity
In highly pretreated histone lysine N-methyltransferase 2A (KMT2A)-rearranged acute leukemia, a small molecule ...
FEBRUARY 9, 2024
Oral Chemo Monitoring Program Shows Value of Clinical Specialty Pharmacists
Increasing interactions between clinical specialty pharmacists and patients taking oral chemotherapy can help ...
APRIL 7, 2022
Next-Generation Sequencing Helps Risk-Stratify Pediatric Leukemia Patients
By accurately assessing minimal residual disease status, next-generation sequencing is showing promise for more ...
JANUARY 26, 2022
